Breast Cancer Vaccine Tests German Merck's $1 Billion Strategy

Breast Cancer Vaccine Tests German Merck's $1 Billion Strategy
Bloomberg - 42 minutes ago
By Naomi Kresge Nov. 4 (Bloomberg) -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology ...